Total Payments
$4,913
2024 Payments
$296.28
Companies
45
Transactions
250
Medicare Patients
2,874
Medicare Billing
$357,983
Payment Breakdown by Category
Food & Beverage$3,933 (80.1%)
Consulting$675.00 (13.7%)
Education$305.00 (6.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,933 | 248 | 80.1% |
| Consulting Fee | $675.00 | 1 | 13.7% |
| Education | $305.00 | 1 | 6.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Palette Life Sciences, Inc. | $697.96 | 2 | $0 (2020) |
| ABBVIE INC. | $502.17 | 37 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $492.82 | 50 | $0 (2024) |
| QOL Medical, LLC | $316.37 | 23 | $0 (2024) |
| Medical Device Business Services, Inc. | $305.00 | 1 | $0 (2021) |
| Braintree Laboratories, Inc. | $284.23 | 12 | $0 (2024) |
| Baxter Healthcare | $242.83 | 2 | $0 (2023) |
| Novum Pharma, LLC | $196.76 | 13 | $0 (2019) |
| Axonics, Inc. | $186.25 | 7 | $0 (2023) |
| Amgen Inc. | $149.77 | 8 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $296.28 | 15 | ABBVIE INC. ($89.79) |
| 2023 | $722.70 | 24 | Baxter Healthcare ($242.83) |
| 2022 | $382.22 | 17 | Braintree Laboratories, Inc. ($159.67) |
| 2021 | $873.94 | 48 | Medical Device Business Services, Inc. ($305.00) |
| 2020 | $1,084 | 37 | Palette Life Sciences, Inc. ($697.96) |
| 2019 | $346.18 | 25 | Medtronic USA, Inc. ($91.99) |
| 2018 | $612.75 | 40 | AbbVie, Inc. ($98.57) |
| 2017 | $594.72 | 44 | Amgen Inc. ($103.37) |
All Payment Transactions
250 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug), SUTAB | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: GI COLON PREP | ||||||
| 11/21/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/27/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Gastroenterology | ||||||
| 08/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/01/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $21.21 | General |
| Category: THERAPY FOR CSID | ||||||
| 07/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Gastroenterology | ||||||
| 07/17/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: ONCOLOGY | ||||||
| 06/07/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/12/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: Immunology | ||||||
| 02/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/06/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $35.70 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/01/2023 | Axonics, Inc. | Bulkamid (Device) | Food and Beverage | In-kind items and services | $36.82 | General |
| Category: Urology | ||||||
| 11/30/2023 | Axonics, Inc. | Bulkamid (Device) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Urology | ||||||
| 11/28/2023 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $31.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/09/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/25/2023 | Axonics, Inc. | Bulkamid (Device) | Food and Beverage | In-kind items and services | $113.04 | General |
| Category: Urology | ||||||
| 10/24/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/31/2023 | Braintree Laboratories, Inc. | SUFLAVE (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: GI COLON PREP | ||||||
| 08/01/2023 | Axonics, Inc. | Bulkamid (Device) | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: Urology | ||||||
| 06/28/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Oncology | ||||||
| 06/20/2023 | Baxter Healthcare | — | Food and Beverage | In-kind items and services | $147.02 | General |
| Category: Surgical Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 778 | 947 | $1.1M | $99,417 |
| 2022 | 15 | 787 | 920 | $1.2M | $106,601 |
| 2021 | 15 | 716 | 822 | $751,275 | $93,193 |
| 2020 | 14 | 593 | 661 | $396,865 | $58,773 |
Total Patients
2,874
Total Services
3,350
Medicare Billing
$357,983
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2023 | 114 | 125 | $115,890 | $13,466 | 11.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 158 | 217 | $33,150 | $10,395 | 31.4% |
| 46500 | Injection of hemorrhoid | Office | 2023 | 30 | 36 | $110,352 | $10,333 | 9.4% |
| 45300 | Diagnostic exam of rectum and lower large bowel using an endoscope | Office | 2023 | 67 | 79 | $252,563 | $9,003 | 3.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 72 | $16,465 | $7,635 | 46.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $33,432 | $7,302 | 21.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 79 | 79 | $43,550 | $6,817 | 15.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 37 | 37 | $151,910 | $5,956 | 3.9% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2023 | 18 | 23 | $86,463 | $5,886 | 6.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 77 | $14,946 | $5,328 | 35.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 21 | 22 | $123,200 | $4,727 | 3.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 56 | 56 | $32,231 | $3,495 | 10.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 31 | $7,025 | $3,231 | 46.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 20 | $12,600 | $3,090 | 24.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $89,380 | $2,753 | 3.1% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2022 | 116 | 129 | $117,980 | $14,492 | 12.3% |
| 46500 | Injection of hemorrhoid | Office | 2022 | 34 | 43 | $127,592 | $13,273 | 10.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 126 | 174 | $34,781 | $13,004 | 37.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 125 | 125 | $71,625 | $11,971 | 16.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 56 | 57 | $237,690 | $9,633 | 4.1% |
| 45300 | Diagnostic exam of rectum and lower large bowel using an endoscope | Office | 2022 | 75 | 78 | $246,649 | $8,880 | 3.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $30,732 | $6,814 | 22.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 61 | $21,025 | $5,659 | 26.9% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2022 | 18 | 20 | $72,448 | $5,243 | 7.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 39 | $8,750 | $4,136 | 47.3% |
About Dr. Jeffrey Aronoff, MD
Dr. Jeffrey Aronoff, MD is a Colon & Rectal Surgery healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699869883.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Aronoff, MD has received a total of $4,913 in payments from pharmaceutical and medical device companies, with $296.28 received in 2024. These payments were reported across 250 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($3,933).
As a Medicare-enrolled provider, Aronoff has provided services to 2,874 Medicare beneficiaries, totaling 3,350 services with total Medicare billing of $357,983. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Colon & Rectal Surgery
- Location New York, NY
- Active Since 10/03/2006
- Last Updated 07/08/2007
- Taxonomy Code 208C00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1699869883
Products in Payments
- Solesta (Device) $697.96
- XIFAXAN (Drug) $322.45
- LINZESS (Drug) $207.70
- SUCRAID (Drug) $197.56
- Humira (Biological) $193.58
- Bulkamid (Device) $186.25
- SUTAB (Drug) $176.09
- INTERSTIM (Device) $158.62
- TRULANCE (Drug) $157.30
- Alcortin A (Drug) $142.43
- Entyvio (Biological) $126.47
- Sucraid (Drug) $118.81
- Repatha (Biological) $118.17
- STELARA (Biological) $108.18
- GATTEX (Drug) $100.90
- TISSEEL (Device) $95.81
- Trulance (Drug) $65.17
- Seglentis (Drug) $56.40
- ENTEREG (Drug) $53.40
- CLENPIQ (Drug) $51.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Colon & Rectal Surgery Doctors in New York
Richard Whelan, M.d, M.D
Colon & Rectal Surgery — Payments: $46,454
Colon & Rectal Surgery $46,454
Dr. Mehraneh Jafari, Md, MD
Colon & Rectal Surgery — Payments: $40,639
Colon & Rectal Surgery $40,639
Dr. Parul Shukla, M.d, M.D
Colon & Rectal Surgery — Payments: $28,695
Colon & Rectal Surgery $28,695
Dr. David Schwartzberg, M.d, M.D
Colon & Rectal Surgery — Payments: $25,515
Colon & Rectal Surgery $25,515
Dr. Juliet Ray, M.d, M.D
Colon & Rectal Surgery — Payments: $16,290
Colon & Rectal Surgery $16,290
Dr. Debbie Bakes, M.d, M.D
Colon & Rectal Surgery — Payments: $15,834
Colon & Rectal Surgery $15,834